CDx Diagnostics THE NEW STANDARD FOR QUALITY GI CARE

Similar documents
Gastroenterology and Hepatology, Mount Sinai West & Mount Sinai St. Luke s Hospitals, New York, NY, USA, 2

ACG Clinical Guideline: Diagnosis and Management of Barrett s Esophagus

Management of Barrett s Esophagus. Case Presentation

New Developments in the Endoscopic Diagnosis and Management of Barrett s Esophagus

American Journal of Gastroenterology. Volumetric Laser Endomicroscopy Detects Subsquamous Barrett s Adenocarcinoma

What s New in the Management of Esophageal Disease

Current Management of Low-Grade Dysplasia in Barrett Esophagus

Barrett s Esophagus: What to Do for No Dysplasia, LGD, and HGD?

Management of Barrett s: From Imaging to Resection

Volumetric laser endomicroscopy can target neoplasia not detected by conventional endoscopic measures in long segment Barrett s esophagus

Barrett s esophagus. Barrett s neoplasia treatment trends

Histopathology of Endoscopic Resection Specimens from Barrett's Esophagus

Gregory G. Ginsberg, M.D.

Learning Objectives:

Quality ID #249 (NQF 1854): Barrett s Esophagus National Quality Strategy Domain: Effective Clinical Care

Quality ID #249 (NQF 1854): Barrett s Esophagus National Quality Strategy Domain: Effective Clinical Care

AGA SECTION. Gastroenterology 2016;150:

Barrett s esophagus (BE) is a precancerous state

Barrett s Esophagus: Review of Diagnostic Issues and Pre- Neoplastic Lesions

Faculty Disclosure. Objectives. State of the Art #3: Referrals for Gastroscopy (focus on common esophagus problems) 24/11/2014

Barrett's Esophagus: Sorting Out the Controversy

What Every Pathologist Wants the GI Nurse to Know (and how you can help us help you)

ASGE and AGA Issue Consensus Statement on Surveillance and Management of Dysplasia in Patients With Inflammatory Bowel Disease

Geisinger Clinic Annual Progress Report: 2011 Nonformula Grant

Page 1. Is the Risk This High? Dysplasia in the IBD Patient. Dysplasia in the Non IBD Patient. Increased Risk of CRC in Ulcerative Colitis

Confocal Laser Endomicroscopy

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

Dysplas'c Barre- s Esophagus: Cut, Burn, Freeze or Watch Very Very Closely

Barrett s Esophagus. Radiofrequency Ablation with the HALO Technology A Reference Book

Present Day Management of Barrett s Esophagus

5th ANNUAL BRONX LIVE ENDOSCOPY COURSE

From reflux to esophageal cancer. Josh Boys, MD TCV 2 nd year indentured servant

Medical Policy. MP Confocal Laser Endomicroscopy

MANAGEMENT OF BARRETT S RELATED NEOPLASIA IN 2018

DISCLOSURES. This program meets the requirements for GI specific Category 1 contact hours. M

Barrett s Esophagus: Ablate Everyone?

Slide 1. Slide 2. Slide 3 DISCLOSURES EXPECTED OUTCOMES DIAGNOSIS AND TREATMENT

Joel A. Ricci, MD SUNY Downstate Medical Center Department of Surgery

Comparison of Endoscopic and Clinical Characteristics of Patients with Familial and Sporadic Barrett s Esophagus

Changes to the diagnosis and management of Barrett s Oesophagus

7 th Annual GASTROENTEROLOGY AND HEPATOLOGY SYMPOSIUM LOCATION: Harbor Beach Marriott Fort Lauderdale, Florida

THE AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 97, No. 1, by Am. Coll. of Gastroenterology ISSN /02/$22.00

Chromoendoscopy or Narrow Band Imaging with Targeted biopsies Should be the Cancer Surveillance Endoscopy Procedure of Choice in Ulcerative Colitis

Barrett s Esophagus: Old Dog, New Tricks

Frozen Section Analysis of Esophageal Endoscopic Mucosal Resection Specimens in the Real-Time Management of Barrett s Esophagus

Everything Esophagus: Barrett s Esophagus. Nicholas Shaheen, MD, MPH Center for Esophageal Diseases and Swallowing University of North Carolina

Paris classification (2003) 삼성의료원내과이준행

RADIOFREQUENCY ABLATION OR CRYOABLATION FOR ESOPHAGEAL DISORDERS

The incidence of esophageal adenocarcinoma is rising in the ENDOSCOPY CORNER

ORIGINAL ARTICLE: Clinical Endoscopy

The Pathologist s Role in the Diagnosis and Management of Neoplasia in Barrett s Oesophagus Cian Muldoon, St. James s Hospital, Dublin

Adherence to Surveillance Guidelines in Nondysplastic Barrett s Esophagus.

The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters.

Accepted Manuscript. CGH Editorial: Sound the Alarm for Barrett s Screening! Tarek Sawas, M.D., M.P.H., David A. Katzka, M.D

Current Management: Role of Radiofrequency Ablation

Technical and Endoscopic Factors in. in CDH1 Mutation Carriers

Sex and race and/or ethnicity differences in patients undergoing radiofrequency ablation for Barrett's esophagus: results from the U.S. RFA Registry.

Cryospray ablation using pressurized CO 2 for ablation of Barrett s esophagus with early neoplasia: early termination of a prospective series

Ablation for Barrett s Esophagus: Burn or Freeze

Endoscopic Management of Barrett s Esophagus

Barrett s Esophagus. Abdul Sami Khan, M.D. Gastroenterologist Aurora Healthcare Burlington, Elkhorn, Lake Geneva, WI

Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia

Gland ducts and multilayered epithelium in mucosal biopsies from gastroesophageal-junction region are useful in characterizing esophageal location

During the past 30 years, the incidence of esophageal ORIGINAL ARTICLES

National & International Lectures

How to characterize dysplastic lesions in IBD?

Barrett s Esophagus. lining of the lower esophagus that bears his name (i.e., Barrett's esophagus). We now

The increasing incidence of esophageal adenocarcinoma

Confocal Laser Endomicroscopy. Description

Inflammatory Bowel Disease Conference Friday, November 22, 2013

Pancreatic Cystic Neoplasms: Guidelines and beyond

Quantitative analysis of high-resolution microendoscopic images for diagnosis of neoplasia in patients with Barrett s esophagus

References. GI Biopsies. What Should Pathologists Assistants Know About Gastrointestinal Histopathology? James M Crawford, MD, PhD

NIH Public Access Author Manuscript Gastrointest Endosc. Author manuscript; available in PMC 2012 July 13.

Barrett s Esophagus: State of the Art. Food Getting Stuck

Endoscopic Radiofrequency Ablation or Cryoablation for Barrett s Esophagus

Effectiveness and Costs of Osteoporosis Screening and Hormone Replacement Therapy, Vol. I: Cost-Effectiveness Analysis.

This medical position statement considers a series of

*Please see amendment for Pennsylvania Medicaid at the

Biliary Tract Malignancy-Cyto/FISH

ACG Clinical Guideline: Evidenced Based Approach to the Diagnosis and Management of Esophageal Eosinophilia and Eosinophilic Esophagitis (EoE)

Is Radiofrequency Ablation Effective In Treating Barrett s Esophagus Patients with High-Grade Dysplasia?

Oesophagus and Stomach update dysplasia and early cancer

Endoscopic Submucosal Dissection ESD

Burning Issues in the Esophagus

Patterns of recurrent and persistent intestinal metaplasia after successful radiofrequency ablation of Barrett s esophagus

Barrett s esophagus (BE), a known complication of chronic

FEP Medical Policy Manual

FEP Medical Policy Manual

ACG Clinical Guideline: Diagnosis and Management of Barrett s Esophagus

Treat Barrett s, Remove the Risk. HALO System

Definition of GERD American College of Gastroenterology

Identifying Intestinal Metaplasia at the Squamocolumnar Junction by Using Optical Coherence Tomography

Imaging techniques in the diagnosis, staging and follow up of GI cancers. Moderators: Banke Agarwal, MD and Paul Schultz, MD

Welcome from the chairpersons Manuel Hidalgo, Beth Israel Deaconess Medical Center, Boston, MA

Chromoendoscopy - Should It Be Standard of Care in IBD?

YOUR CARDIOTHORACIC SURGERY TEAM

Current Controversies in Benign Pancreatic Disease. Thursday, March 16, :00am 3:30pm

In 1998, the American College of Gastroenterology issued ALIMENTARY TRACT

ACG Clinical Guideline: Diagnosis and Management of Gastroesophageal Reflux Disease

Transcription:

CDx Diagnostics THE NEW STANDARD FOR QUALITY GI CARE

STUDYDESIGN 16 major academic GI centers participated in a double-blind, randomized, crossover study in which 160 high-risk patients undergoing BE surveillance were subjected to WATS 3D and Seattle Protocol 4-quadrant forceps biopsies every 1-2 cm. *Vennalaganti PR, Eisen G, Falk GW, et al. Increased Detection of Barrett s Esophagus-Associated Neoplasia Using Wide Area Transepithelial Sampling in Conjunction with 4-Quadrant Forceps Biopsies: Final Results from a Multi-Center, Prospective, Randomized Trial. Gastrointestinal Endoscopy. http://dx.doi.org/10.1016/j.gie.2017.07.039 WATS 3D SEATTLE PROTOCOL STUDYAUTHORS Prashanth R. Vennalaganti MD Julian Abrams, MD, MPH Ram Chuttani, MD Glenn Eisen, MD, MPH Gary W. Falk, MD, MS Lauren B. Gerson, MD John R. Goldblum, MD Seth A. Gross, MD Neil Gupta, MD, MPH Gregory B. Haber, MD Anthony Infantolino, MD Prasad G. Iyer, MD, MS, MPH David A. Johnson, MD Vivek Kaul, MD Shivangi Kothari, MD Charles J. Lightdale, MD Douglas K. Pleskow, MD Felice Schnoll-Sussman, MD Nicholas J. Shaheen, MD Michael S. Smith, MD Kenneth K. Wang, MD Yaxia Zhang, MD Prateek Sharma, MD (Lead Author ) University of Kansas School of Medicine, Kansas City, KS Columbia University School of Medicine, New York, NY Beth Israel Deaconess Medical Center, Boston, MA Stanford University, Palo Alto, CA University of Pennsylvania School of Medicine, Philadelphia, PA Stanford University, Palo Alto, CA Cleveland Clinic, Cleveland, OH New York City Langone Medical Center, New York, NY Loyola University Medical Center, Maywood, IL New York City Langone Medical Center, New York, NY Thomas Jefferson University School of Medicine, Philadelphia, PA Mayo Clinic, Rochester, MN Eastern VA Medical School, Norfolk, VA University of Rochester, Rochester, NY University of Rochester, Rochester, NY Columbia University School of Medicine, New York, NY Beth Israel Deaconess Medical Center, Boston, MA Weill Cornell Medical Center, New York, NY University of North Carolina School of Medicine, Chapel Hill, NC Temple University School of Medicine Philadelphia, PA Mayo Clinic, Rochester, MN Cleveland Clinic, Cleveland, OH University of Kansas School of Medicine, Kansas City, KS

BREAKTHROUGHSAMPLING Finally, you can address the sampling limitations of random forceps biopsy Barrett s esophagus (BE) and dysplasia are often missed with 4-quadrant biopsies Wide area sampled by WATS helps find abnormality located between forceps biopsy samples WATS wider area sample sharply increases routine detection of BE and dysplasia (see bar chart) BREAKTHROUGHANALYSIS 3D imaging yields critical diagnostic information including the en face view of the gland If standard tissue sectioning were applied to a WATS sample, critical diagnostic information would be destroyed Analogous to a CAT scan, WATS computer imaging synthesizes up to 50, 2D optical slices of each 3 micron focal plane into a single 3D image of the entire 150 micron thick specimen This computer synthesized WATS 3D image presents to the pathologist the in vivo, en face view of the gland allowing for a definitive diagnosis of dysplasia in cases which would otherwise be reported as indefinite Forceps Biopsy obtains focal samples. WATS 3D Biopsy obtains a complete sample of a large surface area. How capturing the en face view of the gland helps to eliminate Indefinite for Dysplasia Reports: At the current time, endoscopists rely solely on taking small random forceps biopsies, at 1-2 cm intervals, leaving more than 96% of the endoscopically suspect area completely untested. A WATS sample is 50x thicker than a standard 3μ thick histopathology slide Non-dysplastic epithelium is characterized by a regular honeycomb pattern WATS computer synthesis of 50, 2D optical slices forms an in vivo 3D image of the uncut glandular surface. Prashanth R. Vennalaganti, MD, University of Kansas, School of Medicine, Kansas City, KS Effacement of this honeycomb is a characteristic sign of dysplasia

BREAKTHROUGHDATA BREAKTHROUGHCONSISTENCY Computer assisted technology yields sharply higher inter-observer agreement among pathologists1 Increased Diagnostic Yield with Adjunctive Use** of WATS3D WATS neural network highlights the most suspicious areas on this computer synthesized image areas for consistent pathologist review 428%5 450.0% Barrett s Esophagus 400.0% Dysplasia All Forms 350.0% HGD / EAC 300.0% 242%3 250.0% 200.0% 150.6%3 150.0% 100.0% 50.0% 0.0% WATS not only addresses the sampling error inherent in relying on random forceps biopsies, its three-dimensional computer assisted analysis of the tissue sample provides the GI pathologist with diagnostic information that is not typically available using standard tissue based histopathology. 4,203 12,889 87.5%4 88.5%2 1,266 4,203 12,889 **WATS as an adjunct to standard forceps biopsy compared with standard forceps biopsy alone 3D Robert D. Odze, MD, Director of the GI Pathology Division at the Brigham and Women s Hospital and the Professor of Pathology at the Harvard Medical School 83%2 These robust data demonstrate we have a tool that markedly improves our ability to detect dysplasia and cancer within Barrett s well beyond the error-prone Seattle protocol. Michael S. Smith, MD, MBA, Chief of Gastroenterology and Hepatology, Mount Sinai West and Mount Sinai St. Luke s Hospitals, NY 160 I see no reason why every academic and community gastroenterologist should not be using this rapidly performed, easily implemented procedure today to improve the diagnosis of Barrett s esophagus and dysplasia, so patients can be directed to appropriate endoscopic surveillance or therapy to prevent esophageal cancer. Dr. Charles Lightdale, MD, Columbia University Medical Center, New York OVERCOME RANDOM BIOPSY SAMPLING ERROR STARTING WITH YOUR NEXT EGD. Please contact us today at 1-866-363-6239 or wats3d@cdxdiagnostics.com. to learn how easy it is to let WATS3D help your next EGD be far more reliable.

1 Vennalaganti PR, Kanakandi VN, Gross SA, et al. Inter-observer agreement among pathologists using wide-area transepithelial sampling with computer-assisted analysis in patients with Barrett s esophagus.am J Gastroenterol. 2015;110(9):1257-1260 2 Gross SA, Smith M, Ali R, Kaul V on behalf of US Collaborative WATS3D Study Group. Increased detection of Barrett s esophagus and esophageal dysplasia using transepithelial brush biopsy with three dimensional computer-assisted tissue analysis: a prospective multi-site community-based study. United Eur Gastroenterol J. 2015;3(5S):A103. 3 Ikonomi EP, Bhuta R, Iorio N, et al. Transepithelial brush biopsies with computer-assisted 3-dimensional analysis markedly improve detection of Barrett s esophagus and dysplasia: interim analysis from a prospective multi-center community-based study. Am J Gastroenterol. 2015;110(Suppl 1):S728. 4 Johansen JF, Frakes J, Eisen D, et al. Computer-assisted analysis of abrasive transepithelial brush biopsies increases the effectiveness of esophageal screening: a multicenter prospective clinical trial by the EndoCDx Collaborative Group. Dig Dis Sci. 2011;56(3):767-772. 5 Vennalaganti PR, Eisen G, Falk GW, et al. Increased Detection of Barrett s Esophagus-Associated Neoplasia Using Wide Area Transepithelial Sampling in Conjunction with 4-Quadrant Forceps Biopsies: Final Results from a Multi-Center, Prospective, Randomized Trial. Gastrointestinal Endoscopy. http://dx.doi.org/10.1016/j.gie.2017.07.039 CDx Diagnostics Two Executive Boulevard, Suffern, New York 10901 www.wats3d.com Client Services (866) 363-6239 CDx Diagnostics 2017-18